Hummer Law Offices: 10333 Seminole Blvd. Suite 14, Largo, Florida 33778. Phone: 727-397-9198
Hummer Law Offices is a licensed Florida attorney for defective medical products in Tampa Bay, Florida. Our law office represents registered claimants in the Settlement For Dow Corning Trust (SFDCT)- DC Settlement - Dow Corning Breast Implants Settlement - Hip Implant Recall - Knee Implant Recall - Merina - Actos - Fosmas & Boniva - Byetta, Januvia, & Janumet - GranFlo - NaturalLyte - Lipitor - Testosterone - Viagra- Xarelto - Yaz, Yasmin and Ocella Litigation Attorneys - Kugel Hernia Mesh Patch - Infusion Pumps - Pain Pumps - Asbestos - GM Ignition Switch Litigation Lawyer In Pinellas County, Florida - Attorney For Social Security Disability In Largo, Seminole, St. Petersburg, Tampa, FL If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your client's copyright, please contact us concerning copyright matters.
Expedited Release Checks Important Please Read The Settlement Facility Dow Corning Trust has recently decided to send Expedited Release Payments ($2,000) to all claimants whose cases are idle. The Dow Settlement criteria states that if you accept this payment you can NEVER apply for a disease claim in the future, even if you become sick. If you receive one of these checks in the mail, please do not cash it until you speak with an attorney to discuss your potential claim. Again, if you cash this check you have effectively settled your claim and can never get any additional money.
SFDCT Medical Criteria Learn about the medical criteria that you will need to meet in order to submit a disease claim through the SFDCT Settlement.
Death or total disability due to the compensable condition. An individual shall be considered totally disabled if she demonstrates a functional capacity adequate to consistently perform none or only few of the usual duties or activities of vocation or self-care.
A Breast Implant Claimant will be eligible for category B compensation if she is 35% disabled due to the compensable condition. An individual shall be considered 35% disabled if she demonstrates a loss of functional capacity which renders her unable to perform some of her usual activities of vocation, avocation, and self-care, or if she can only perform them with regular or recurring severe pain.
A Breast Implant Claimant will be eligible for category C compensation if she is 20% disabled due to the compensable condition. An individual shall be considered 20% disabled if she can perform some of her usual activities of vocation, avocation, and self-care only with regular or recurring moderate pain.
Diffuse cutaneous scleroderma,
Limited cutaneous scleroderma, or
Sine scleroderma, occurring concomitantly with diagnosis of systemic lupus erythematosus, inflammatory muscle disease, or rheumatoid arthritis. See Kelley et al., Table 66-2, at 1114.
Death or total disability resulting from MCTD or Overlap Syndrome. An individual will be considered totally disabled based on the functional capacity test set forth in Severity/Disability Category A of Atypical Connective Tissue Disease/Atypical Rheumatic Syndrome.
MCTD or Overlap Syndrome, plus major organ involvement or major disease activity including central nervous system, cardio-pulmonary, vasculitic, or renal involvement or hemolytic anemia (marked) or thrombocytopenic purpura or severe granulocytopenia.defined as synovial swelling and tenderness in three (3) or more joints lasting greater than six (6) weeks and observed by a physician.
A diagnosis of mixed connective tissue disease (MCTD) shall be based on the presence of clinical symptoms characteristic of two (2) or more rheumatic diseases (systemic sclerosis, SLE, myositis, and Rheumatoid Arthritis), accompanied by positive RNP Antibodies. See. e.g., Kelley, et al. Table 63-1, at 1061.
Overlap Syndrome is defined as anyone (1) of the following three (3):
The application of the above diagnostic criteria is not intended to exclude from the compensation program individuals who present clinical symptoms or laboratory findings atypical of MCTD but who nonetheless have an Overlap Syndrome, except that an individual will not be compensated in this category if her symptomology more closely resembles an atypical connective tissue disease condition/atypical rheumatic syndrome/non-specific autoimmune condition.